Why low-cost ketamine is still inaccessible to many with severe depression

by

A case study on ketamine reveals systemic barriers that prevent repurposing existing low-cost drugs like ketamine for treatment-resistant depression.

Leave A Comment

Your email address will not be published. Required fields are marked *